SCHEMBL20006549

SCHEMBL20006549

NC(=O)c1ccc2c(c1)CCC1C2CCC23CC2=CCC13

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 8/20 0.67
HSD17B1 P14061 4/20 0.48
ESR1 P03372 3/20 0.47
CYP3A4 P08684 2/20 0.46
SRD5A2 P31213 2/20 0.46
STS P08842 3/20 0.45
ESR2 Q92731 2/20 0.45
AKR1B10 O60218 1/20 0.45
LMNA P02545 1/20 0.45
SHBG P04278 1/20 0.45
CYP1A2 P05177 1/20 0.45
PGR P06401 1/20 0.45
SERPINA6 P08185 1/20 0.45
AR P10275 1/20 0.45
MAPT P10636 1/20 0.45
CYP19A1 P11511 1/20 0.45
AKR1B1 P15121 1/20 0.45
NFKB1 P19838 1/20 0.45
SLC6A4 P31645 1/20 0.45
OPRM1 P35372 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15971652 0.81 AKR1C3 (1.00) AKR1C3HSD17B1ESR1CYP3A4STS
SCHEMBL15973918 0.79 STS (0.73) AKR1C3HSD17B1ESR1CYP3A4STS
SCHEMBL15625977 0.79 STS (0.73) AKR1C3HSD17B1ESR1CYP3A4STS
SCHEMBL12966596 0.79 STS (0.73) AKR1C3HSD17B1ESR1CYP3A4STS
SCHEMBL20006619 0.77 AKR1C3 (0.56) AKR1C3HSD17B1ESR1CYP3A4STS
SCHEMBL14817226 0.77 AKR1C3 (0.66) AKR1C3HSD17B1ESR1CYP3A4SRD5A2
SCHEMBL17465596 0.77 AKR1C3 (0.69) AKR1C3HSD17B1ESR1CYP3A4STS
SCHEMBL20006554 0.77 AKR1C3 (0.69) AKR1C3HSD17B1ESR1CYP3A4STS
SCHEMBL15973525 0.77 AKR1C3 (0.69) AKR1C3HSD17B1ESR1CYP3A4STS
SCHEMBL15973523 0.77 AKR1C3 (0.69) AKR1C3HSD17B1ESR1CYP3A4STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2958928-B1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) Bayer Pharma AG (DE) 2018-03-28 EP disclosed